Yasin Keshvargar
Lawyers
Filters
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Terns Pharmaceuticals $86 million stock offering
The stock is listed on the Nasdaq Global Select Market
Lantheus Holdings $575 million convertible senior notes offering
The 2.625% convertible notes are due 2027
Brookdale Senior Living $125 million tangible equity units offering
The offering comprised 2.5 million units
Ormat Technologies $338 million secondary offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
XPO Logistics cash tender offer
The tender offer involves 6.25% senior notes due 2025
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
RXO $355 million notes offering
The notes are being offering in connection with the intended spinoff of RXO
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares